Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-14

Clinical Trial Update: Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection [Phase 1, Phase 2]

View source ↗

Summary

Clinical trials evaluating putative investigational therapeutics for Ebola Virus Infection are completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Ebola Virus Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-05-14